SPECTRALMD DEEPVIEW WOUND IMAGING SYSTEM

by Spectral AI  · Based in United States → — Wound Imaging and Assessment | Predictive Analytics | Spectral AI
Dermatology General Surgery Plastic Surgery

Contact for pricing
Regulatory Status Disclosed

Overview

The Spectral AI DeepView Wound Imaging System is an advanced, non-invasive diagnostic platform that leverages multispectral imaging and proprietary artificial intelligence (AI) algorithms to provide clinicians with immediate, objective insights into wound healing potential. Designed to visualize tissue characteristics not visible to the human eye, the DeepView System assists healthcare professionals in making faster and more accurate treatment decisions for various wound types.

The system captures images across visible and near-infrared light wavelengths to analyze tissue viability and blood perfusion. Its AI algorithms integrate image and clinical data, comparing it against a robust, clinically validated database (including the world’s largest burn biopsy tissue database) to predict healing outcomes. This technology offers a ‘Day One’ healing assessment, providing a simple ‘Yes/No’ prediction of whether a wound will heal or require surgical intervention, thereby guiding therapeutic procedures and optimizing patient care pathways.

Initially developed as a medical countermeasure for mass casualty events, the DeepView System is now applied in everyday clinical settings. It is a portable imaging platform with a user-friendly touch-screen display, designed for ease of use across various healthcare environments. The system aims to transform wound care management by improving diagnostic accuracy, reducing unnecessary procedures, and streamlining workflows for both acute and chronic wounds.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Multispectral imaging technology
  • Proprietary AI algorithms for wound healing prediction
  • Non-invasive and radiation-free imaging
  • Real-time, objective wound assessment
  • Diagnostic 'Day One' healing assessment
  • Rapid image acquisition (approx. 2 seconds)
  • Portable imaging platform
  • EHR connectivity option
  • Digital wound assessment and documentation
  • Trained on extensive clinical burn database

Use Cases

  • Burn wound assessment and triage
  • Diabetic foot ulcer healing prediction
  • Chronic wound management
  • Acute wound care decision support
  • Plastic and reconstructive surgery planning
  • Assessment of tissue blood perfusion

What Physicians Need to Know

Key Capabilities
The DeepView Wound Imaging System uses multispectral imaging and AI to provide immediate wound healing predictions, offering insights not visible to the human eye. It can assess the healing potential of thermal burn wounds in real-time, highlighting areas unlikely to heal within 21 days that may require surgical intervention. The system also measures Total Body Surface Area (TBSA). Image acquisition is fast (0.2 seconds), with processing and AI model classification taking approximately 20-25 seconds.
Clinical Utility
DeepView aids in faster and more accurate treatment decisions for burn patients, supporting triage assessment and surgical planning. It provides objective, data-driven assessments to reduce variability in wound evaluation, especially within the critical first 24-48 hours post-injury. The system is intended for use in burn centers, trauma centers, and emergency departments. It has also been explored for use in diabetic foot ulcers (DFUs) and as a medical countermeasure for mass casualty incidents.
Integration Options
The DeepView AI System is being designed to integrate with electronic health records (EHRs) and existing clinical workflows. Spectral AI owns its cloud-based data pipeline, from patient data collection to meaningful output for clinicians.
Compliance Status
The DeepView System received De Novo Classification from the U.S. Food and Drug Administration (FDA) in May 2026, authorizing commercial distribution in the United States. It also received initial UKCA (UK Conformity Assessed) authorization in the United Kingdom in February 2024. The technology was designated as a Breakthrough Device by the FDA for its burn indication in 2018. Spectral AI completed ISO 13485 certification audit for the manufacture and distribution of the system, with certification anticipated in Q3 2023.
Pricing Model
Spectral AI is pursuing additional reimbursement opportunities, including an application for NTAP (New Technology Add-on Payment) status from CMS. If approved, NTAP payment status could be available starting October 2027 for approximately three years, potentially covering around 65% of the estimated cost of the new technology.
User Experience
The system is designed to be non-invasive, painless, and radiation-free. It is described as quick to use, with image acquisition taking a fraction of a second, which is beneficial for patients in pain or discomfort. The cart-based system offers exceptional mobility within healthcare settings. User research was conducted to ensure the device aligns with clinical workflows and enhances diagnostic capabilities, with a focus on creating a robust, intuitive, and simple user experience.
Implementation Complexity
The DeepView System is designed to integrate with existing clinical workflows, making it easier for clinicians to incorporate wound imaging and healing predictions into daily patient treatment plans. The goal is to reduce adoption barriers for health systems.
Evidence Base
The DeepView System is trained and tested against a proprietary and clinically validated database of over 340 billion pixels of burn wound image data. A burn validation study, one of the largest in U.S. history, demonstrated that DeepView outperformed burn physicians in identifying non-healing tissue, achieving 86.6% sensitivity at the image-wise level compared to 40.8% for clinical judgment. At the pixel-wise level, sensitivities were 81.9% for DeepView and 38.8% for physicians. The system also showed higher Dice scores (68.5% vs. 39.2%) for improved pixel-wise evaluation. Early studies on diabetic foot ulcers showed an accuracy of 98% in predicting healing or non-healing at 30 days, with 98% sensitivity and 94% specificity. Results from a 2018 Proof of Concept Study were published in the Journal of Burn Care & Research, indicating its role in aiding earlier diagnosis of burn wounds.
Physician Tip

The DeepView System provides objective, AI-driven insights into burn wound healing potential, which can significantly enhance early treatment decisions and surgical planning. While it supports conventional assessment, it does not replace it. The rapid, non-contact image acquisition is patient-friendly, and the system's ability to identify non-healing tissue with high sensitivity can help prioritize interventions and potentially reduce unnecessary procedures. Consider integrating this tool to standardize wound assessment, especially in emergency and trauma settings where specialized burn expertise may be limited.

The DeepView AI System is being developed with integration into existing Electronic Health Records (EHRs) and clinical workflows in mind to streamline documentation and treatment planning. Spectral AI manages its own cloud-based data pipeline for efficient data handling.

Details

Category Dermatology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentPortable imaging platform with cloud-based data pipeline
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Dermatology, General Surgery, Plastic Surgery

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2017-08-17K163339 510(k)SPECTRALMD DEEPVIEW WOUND IMAGING SYSTEM

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate SPECTRALMD DEEPVIEW WOUND IMAGING SYSTEM

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for SPECTRALMD DEEPVIEW WOUND IMAGING SYSTEM.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

The DeepView Wound Imaging System is a non-invasive, predictive medical device that combines multispectral imaging with a proprietary AI algorithm to assess the healing potential of burn wounds. It works by capturing images using multiple wavelengths of light, analyzing the reflected light to differentiate tissue types, and then applying AI algorithms to predict whether the tissue will heal.
The DeepView System is primarily indicated for thermal burn wounds, providing an objective and immediate assessment of a burn wound's healing potential. This allows physicians to make faster, more informed treatment decisions, potentially leading to earlier interventions and more targeted treatment plans.
In studies, the DeepView System has demonstrated significantly higher sensitivity in identifying non-healing tissue compared to clinical judgment by burn physicians. While physicians showed higher specificity in some areas, DeepView provides objective, standardized insights that can reduce variability in assessment, especially in the critical initial hours post-injury.
The DeepView System received Breakthrough Device Designation from the FDA in 2018 for its burn indication and was granted De Novo Classification by the U.S. Food and Drug Administration in May 2026. It also received its initial UKCA (UK Conformity Assessed) authorization in the United Kingdom in February 2024.
The DeepView System is indicated for thermal burn wounds only, and all dressings and topical agents must be removed prior to scanning. While it provides a high-quality image to support conventional assessment, it is intended to be used in conjunction with clinical judgment and the patient's overall condition.
Alternatives include traditional clinical judgment, which can be subjective, and other imaging technologies like Laser Doppler Imaging (LDI). Other companies like Perceptive Solutions, WoundVision, and Intellicure also offer various wound management and imaging solutions, some with AI capabilities in development.
While specific pricing is not publicly available, Spectral AI is pursuing New Technology Add-On Payment (NTAP) application with the Centers for Medicare & Medicaid Services (CMS) to help offset the costs for hospitals. If approved, NTAP payments could be available starting in October 2027 for approximately three years.

Related Tools

Rash ID
Rash ID
Dermatology AI
Based on the provided official website text, Rash ID (rashid.com) is a domain name that is currently listed for sale on GoDaddy’s aftermarket. The website content does not describe any medical AI tool, its functions, target users, workflow integration, or specific capabilities. Therefore, no information about a medical AI tool named “Rash ID” can be […]
AI-based support system for skin cancer diagnostics
German Cancer Research Center (DKFZ)
Clinical Decision Support & Reference
Scientists at the German Cancer Research Center have developed an AI-based support system for skin cancer diagnostics that explains its decisions, increasing doctors' confidence in both the AI and their own diagnoses.
aisencia
aisencia GmbH
Clinical Decision Support & Reference
aisencia GmbH utilizes an AI system to detect and classify around 40 different skin disorders, supporting pathologists by reducing workload and speeding up diagnoses.
Autoderm
Autoderm
Clinical Decision Support & Reference
Autoderm is an AI-powered API that provides pre-triage and informational condition suggestions for teledermatology platforms, aiming to improve efficiency and case quality.
Derm.AI
Fraunhofer-Gesellschaft (Fraunhofer AICOS) / PALMX APPS LTD / Skin Analytics
Dermatology AI
Derm.AI is an AI-powered mobile app and software designed by Fraunhofer-Gesellschaft to accelerate skin cancer diagnoses.
HistoGPT
AI Agent
Clinical Decision Support & Reference
HistoGPT is an AI tool that automates the generation of high-quality pathology reports from histology images, aiming to transform dermatopathology by enhancing diagnostic accuracy and efficiency.

See all Dermatology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-14 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.